← Back to Clinical Trials
Recruiting NCT07542769

NCT07542769 Choice and Autonomy in Learning Mindfulness for Pediatric Residents

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07542769
Status Recruiting
Phase —
Sponsor Northwestern University
Condition Program Engagement
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2026-04-13
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Wakeful Digital Mindfulness Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2026-04-13 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a pilot clinical trial designed to evaluate a flexible, online mindfulness program for pediatric residents. Medical training can be stressful, and although mindfulness programs are often offered to support well-being, many are either in-person or follow a fixed format that may not fit individual schedules or preferences. This study will test a digital mindfulness program called Wakeful, which allows participants to complete the course at their own pace. Participants will be randomly assigned to one of two groups: one group will be able to choose the length of their mindfulness program (3, 5, or 7 weeks), while the other group will be assigned a program length without a choice. The goal is to understand whether giving participants a choice improves how often they use the program, how satisfied they are with it, and whether they complete it. The main outcomes of this study focus on how participants interact with the program, including how many sessions they complete, how often they practice mindfulness on their own, and how useful and relevant they find the program. The study will also look at overall satisfaction and how many participants drop out before finishing. In addition, the study will explore whether participants report changes in mindfulness and compassion for others, although it is not designed to determine clinical improvements in mental health. By understanding how pediatric residents engage with different program formats, this study aims to inform the design of more flexible and user-centered digital wellness programs that better fit into demanding medical training environments.

Eligibility Criteria

Inclusion Criteria: * Current categorical pediatrics residents at Northwestern University. * Preliminary pediatrics residents who intend to continue in pediatrics. * Willing and able to provide informed consent. Exclusion Criteria: \- None; all pediatric residents meeting inclusion criteria are eligible.

Contact & Investigator

Central Contact

Jason T Tsichlis, MD, MS

✉ jtsichlis@luriechildrens.org

📞 312-227-4000

Frequently Asked Questions

Who can join the NCT07542769 clinical trial?

This trial is open to participants of all sexes, studying Program Engagement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07542769 currently recruiting?

Yes, NCT07542769 is actively recruiting participants. Contact the research team at jtsichlis@luriechildrens.org for enrollment information.

Where is the NCT07542769 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT07542769 clinical trial?

NCT07542769 is sponsored by Northwestern University. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology